Beroni Group Inc (BNIGF:OTCQX) (ASX:BTG) CEO Jacky Zhang sat down with Proactive’s Christine Corrado at the Biotech Showcase 2020 in San Francisco. The Australian-based company currently has four core businesses: research and development of new drugs and clinical trail, immune cell therapy including gene detection and diagnosis, immunotherapy for cancer treatment, diagnosis of infectious diseases and e-commerce based on the Internet sales of pharmaceutical, healthcare and cosmetic products.
Beroni Group looking to up-list to the Nasdaq
Quick facts: Beroni Group
Price: 2.15 USD
Market Cap: $162.8 m
NO INVESTMENT ADVICE
The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...FOR OUR FULL DISCLAIMER CLICK HERE